Patient Guide: Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 12 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03703375
Status: ACTIVE_NOT_RECRUITING
Condition: Lymphoma, T-Cell
Phase: PHASE3

Find a Study Location Near You

This study is available at 12 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Sapporo-shi, Hokkaido
  • Okayama-shi, Okayama
  • Osakasayama, Osaka
  • • And 9 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily